BiPASS Prostate Cancer Study Begins Patient Dosing
January 19, 2026 | 15:27
The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing research into improved diagnostic approaches for prostate cancer detection.
Mobile Version